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De-Differentiation of Mouse Interfollicular
Keratinocytes by the Embryonic Transcription
Factor Oct-4
Katie L. Grinnell1, Baoli Yang2, Richard L. Eckert3 and Jackie R. Bickenbach1,4
The embryonic transcription factor Oct-4 is often referred to as the master regulator of the undifferentiated
state. Although its role in maintaining embryonic stem (ES) cell pluripotency is well established, its ability to
directly reprogram committed somatic cells is not well defined. Using transient transfection, we tested its ability
to revert mouse interfollicular epidermal basal keratinocytes to a more ES cell-like state. We found that the Oct-
4-transfected keratinocytes expressed the Oct-4 target genes, Sox-2, Nanog, undifferentiated transcription
factor 1 (Utf1), and Rex-1. We also noted an increase in developmental potential caused by Oct-4, with the
transfected cells able to differentiate into neuronal cells when exposed to neuroectodermal differentiation
medium. Control-transfected keratinocytes were unable to respond to the medium, and remained as
keratinocytes. These findings suggest that Oct-4 may be the master regulator of the pluripotent state and
demonstrate that differentiated somatic cells can be reverted into more developmentally potent cells through
the use of a single factor. The latter finding has great implications for therapeutic cell-replacement applications
using cells from easily accessible adult tissues, such as the skin.
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INTRODUCTION
The desire to use embryonic stem (ES) cells therapeutically is
based on their developmental potential, that is, the number of
cell types into which they are capable of differentiating.
However, as their use is controversial, it would be of benefit
if adult cells could be made to act more like ES cells. ES cells,
derived from the inner cell mass of developing E3.5-day
mouse or E4.5-day human embryos, are considered pluri-
potent (Ovitt and Scholer, 1998). These cells are capable of
generating all tissues of the adult organism. For over 15 years,
researchers have sought to determine what controls this
ability and if it is possessed by any other cell types.
Scholer et al. (1990a, b) discovered a maternally expressed
octamer-binding protein present in unfertilized oocytes, the
inner cell mass of the blastocyst, and pre-gastrulation
embryonic ectoderm, and in primordial germ cells. Ectopic
expression studies in HeLa cells revealed that this protein,
termed octamer-binding factor 4, or Oct-4, was a transcrip-
tion factor and that it functioned by binding to an octamer
motif (ATTTGCAT) in the promoter or enhancer regions of
specific target genes (Scholer et al., 1990a, b). It is currently
well established that Oct-4 expression is associated with the
undifferentiated phenotype, both in the embryo and in cell
lines derived from it. It serves as a transcriptional regulator for
a number of genes known to be essential for early embryonic
development, activating transcription of those associated
with pluripotency and repressing those linked to differentia-
tion down a specific lineage pathway (Ovitt and Scholer,
1998).
Of the known Oct-4 targets, four have been shown to be
essential for the maintenance of pluripotency: Sox-2,
undifferentiated transcription factor 1 (Utf1), Rex-1, and
Nanog (Ben-Shushan et al., 1998; Fukushima et al., 1998;
Okuda et al., 1998; Nishimoto et al., 1999; Avilion et al.,
2003; Constantinescu, 2003; Mitsui et al., 2003; Okumura-
Nakanishi et al., 2004; Kuroda et al., 2005; Rodda et al.,
2005). The sox-2 locus encodes a Sry family transcription
factor that contains a High Mobility Group domain (Avilion
et al., 2003). Sox-2, which is expressed in the inner cell mass
of the embryo, the epiblast, and primordial germ cells
(Avilion et al., 2003), is not only a target of but also serves
as a cofactor for Oct-4 (Okumura-Nakanishi et al., 2004).
Sox-2 and Oct-4 comprise a regulatory complex, which in
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turn controls the expression of other Oct-4 targets, including
Utf1, Rex-1, and Nanog (Okumura-Nakanishi et al., 2004).
Utf1 is a transcriptional coactivator expressed in pluripotent
ES cells and several embryonic carcinoma cell lines
(Okuda et al., 1998). The Utf1 gene is activated through the
binding of the Oct-4/Sox-2 complex to its enhancer region
(Nishimoto et al., 1999). Its protein product has been shown
to interact with the activation domain of the activating
transcription factor-2 (ATF-2) protein, as well as with the
TFIID complex. Upon differentiation, its expression is rapidly
downregulated (Okuda et al., 1998). Rex-1 is another
transcription factor expressed in undifferentiated ES and
embryonic carcinoma cells under the control of Oct-4. Oct-4
activates transcription of the Rex-1, or Zfp42, gene by
binding to an octamer motif in its promoter. The acidic zinc
finger protein encoded by the locus binds to a number of as
yet unidentified genes in the developing embryo and is
quickly downregulated upon stem cell differentiation (Ben-
Shushan et al., 1998). The most recently discovered Oct-4
target, Nanog (Kuroda et al., 2005; Rodda et al., 2005), was
first identified as a leukemia inhibitory factor/signal transdu-
cers and activators of transcription-3-independent factor
necessary for maintenance of pluripotency (Mitsui et al.,
2003). Once thought to act independently of Oct-4 (Cham-
bers et al., 2003), this homeoprotein is now known to be
activated through binding of the Oct-4/Sox-2 complex to its
promoter (Rodda et al., 2005). Just like Utf1 and Rex-1,
Nanog precisely corresponds to the pluripotent phenotype
and is rapidly extinguished upon differentiation (Kuroda
et al., 2005; Rodda et al., 2005).
Given this relatively defined profile of the pluripotent
state directed by the Oct-4 transcription factor, we
hypothesized that somatic cells could be de-differentiated
through the expression of Oct-4, resulting in an increase in
developmental potency. If true, this could provide a
potential alternative to using ES cells for certain cell-based
disease therapies. We chose to use mouse epidermal
interfollicular basal keratinocytes as our target somatic cell
population because the skin is the largest organ in the
body, thereby providing a large number of cells for study. In
addition, our laboratory has shown that mouse interfollicular
epidermal stem cells, a subset of basal keratinocytes,
are multipotent, demonstrating the ability to populate tissues
derived from all three germ layers when injected into the
developing blastocyst (Liang and Bickenbach, 2002).
Although these epidermal stem cells would be a good
substitution for ES cells, they account for only a small
percent of basal keratinocytes, making it difficult to use
them clinically. Therefore, we tested whether transfecting
interfollicular basal keratinocytes with Oct-4 would
create a larger multipotent population, with properties similar
to the epidermal stem cells. The results presented
here demonstrate that the single transcription factor Oct-4
is capable of reprogramming the somatic mouse keratinocyte
to become more like an ES cell. This reprogramming
results in at least a partial de-differentiation of the keratino-
cyte, which, in turn, leads to an increase in its developmental
potential.
RESULTS
Transient transfection of mouse epidermal interfollicular basal
keratinocytes with mouse Oct-4 leads to nuclear localization of
the transcription factor and a temporally regulated expression
pattern
Based on the transient expression pattern of Oct-4 in the
mouse embryo and its corresponding mode of action, we
hypothesized that for Oct-4 to reprogram differentiated
somatic cells, it would have to be expressed for only a short
time and then attenuated. We therefore introduced the full-
length mouse Oct-4 transcript (cloned from W4/129S6 ES
cells) through transient transfection. We determined how
long it was expressed in our keratinocyte cultures, and if the
protein product was localized correctly. Immediately follow-
ing isolation from neonatal body skin, keratinocytes were
plated onto collagen-coated chamber slides (Nalge Nunc
International, Rochester, NY) and transfected with either a
control plasmid containing green fluorescent protein (GFP) or
a plasmid containing the full-length Oct-4 transcript.
Immunocytochemical analysis performed 48 hours after
transfection revealed that delivery of the full-length transcript
through the pcDNA3 mammalian expression plasmid led to
appropriate nuclear translocation of the Oct-4 protein (see
Figure S1), with an average transfection efficiency of 33%
(Figure 1). The Oct-4 protein level, as determined by Western
blot was 1.5-fold lower than that seen in the W4/129S6 ES
cells (data not shown). None of the cells transfected with the
control pcDNA3-GFP plasmid expressed the Oct-4 protein
(Figure S1).
To examine the temporal expression pattern of Oct-4
following transfection, we examined keratinocytes by immu-
nocytochemical analysis for protein expression at 24, 48, 72,
120, and 168 hours post-transfection (Figure 1). Twenty-four
hours after transfection, GFP was expressed in 16.3372.08%
of control transfected cells and Oct-4 was expressed in
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Figure 1. Percent of keratinocytes expressing either GFP or Oct-4 at various
time points following transient transfection. Gray¼GFP; Black¼Oct-4. At
24 hours post-transfection, GFP is expressed in 16.3372.08% of cells and
Oct-4 is expressed in 13.3374.04% of cells. At 48 hours post-transfection,
expression of both GFP and Oct-4 peaks, with GFP expressing in
42.0075.00% of cells and Oct-4 expressing in 33.3375.03% of cells. By
72 hours, expression of GFP is 32.3372.08% and expression of Oct-4 is
31.6674.16%. After 120 hours, GFP expression is decreased to 2.6772.08%
of cells and Oct-4 expression is decreased to 1.0870.50% of cells and at
168 hours post-transfection, GFP expression is at 1.7270.64% and Oct-4
expression is at 0.3370.10%.
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13.3374.04% of transfected cells. Expression of both GFP
and Oct-4 peaked at 48 hours post-transfection, with GFP
expressed in 42.0075.00% of cells and Oct-4 expressed in
33.3375.03% of cells. By 72 hours, expression of GFP
(32.3372.08%) and Oct-4 (31.6674.16%) was essentially
equal. As expected with transient transfection, expression
was severely reduced by 120 hours, with GFP expressed in
2.6772.08% of cells and Oct-4 expressed in 1.0870.50% of
cells and, at 168 hours post-transfection, GFP expression was
at 1.7270.64% and Oct-4 expression was virtually extin-
guished (0.3370.10%). These results reveal that transient
transfection allows for temporally regulated expression of
Oct-4, with a peak at 48 hours and an almost complete
downregulation between 120 and 168 hours post-transfection
(Figure 1). This expression pattern allowed us to study how
the presence of the embryonic transcription factor Oct-4
altered gene and protein expression in the keratinocytes, as
well as what types of changes occurred after it was no longer
expressed.
Oct-4 induces expression of ES cell genes in mouse epidermal
interfollicular basal keratinocytes
One essential test of whether or not Oct-4 is truly the master
regulator of the pluripotent state is to measure its ability to
re-activate expression of early developmental genes in a
differentiated cell. We examined the expression of the Oct-4-
controlled pluripotency genes Sox-2, Utf1, Rex-1, and
Nanog. Effectiveness of primers for Oct-4 and its target genes
was first confirmed using RNA from the ES cell line, W4/
129Sv (Figure 2a and d). Based on the temporal expression
data collected, we examined gene expression changes in the
transfected keratinocytes at the peak of Oct-4 expression,
48 hours. Mouse skin keratinocytes transfected with the full-
length cDNA transcript in the pcDNA3-Oct-4 plasmid
expressed Oct-4 (Figure 2d) and all of the proposed target
genes (Figure 2c). Keratinocytes transfected with the control
plasmid, pcDNA3-GFP did not express Oct-4 (Figure 2d)
or any of the target genes (Figure 2b). These findings
demonstrate that not only can Oct-4 be expressed in mouse
keratinocytes, but that it can also activate a series of genes
known to be under its control in pluripotent ES cells.
Expression of several embryonic genes persists after
downregulation of Oct-4
After observing that the Oct-4 protein resulting from transient
transfection persisted for about 72 hours (see Figure 1), we
next determined how the presence or absence of the Oct-4
transcript affected the expression of its selected target genes.
By 24 hours after transfection with pcDNA3-Oct-4, the
keratinocytes expressed the Oct-4 transcript (Figure 3b), as
well as Nanog, Utf1, Rex-1, and Sox-2 (Figure 3a). By
72 hours post-transfection, the Oct-4 transcript was expressed
at only a slightly lower level than it was at 24 hours (Figure
3b), whereas Nanog, Utf1, and Rex-1 appeared to be
expressed at slightly higher levels. Sox-2, conversely, seemed
to be downregulated compared with its expression level at
24 hours (Figure 3a). At 120 hours post-transfection, Oct-4
transcript was no longer detectable by reverse transcription
(RT)–PCR (Figure 3b). Nanog and Sox-2 were also undetect-
able (Figure 3a). Utf1 and Rex-1, however, were still
expressed at levels equal to or slightly higher than those
measured after 24 hours (Figure 3a). Thus, Oct-4 needs only
to be introduced transiently in a mouse keratinocyte for it to
reactivate key pluripotency-related genes. Even after it is
downregulated, expression of two of its targets, Utf1 and Rex-
1, is still maintained. Sox-2, the purported cofactor for Oct-4,
exhibits an expression pattern mirroring that of Oct-4. These
results are in accordance with the newest findings (Kuroda
et al., 2005; Rodda et al., 2005) that Nanog is, in fact,
activated by expression of Oct-4.
Oct-4 expression enables mouse keratinocytes to achieve a
neuronal phenotype in response to neuroectodermal growth
conditions
To assess whether or not the expression changes that
occurred in the keratinocytes in response to Oct-4 had
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Figure 2. Keratinocyte expression of Oct-4, Nanog, Utf1, Rex-1, and Sox-2 following transient transfection with full-length Oct-4 cDNA. (a) W4 ES cells (P22)
express Nanog, Utf1, Rex-1, and Sox-2. (b) Keratinocytes (P0) transfected with pcDNA3-GFP do not express the four embryonic genes. Note that the band in the
Utf1 lane is too low to be Utf1 (compare to W4 ES cell and pcDNA3-Oct-4). (c) Keratinocytes (P0) transfected with pcDNA3-Oct-4 express all four of the
embronic genes. (d) Oct-4 expression. W4 ES cells express Oct-4 (lane 2). Keratinocytes transfected with pcDNA3-GFP do not express Oct-4 (lane 3).
Keratinocytes transfected with pcDNA3-Oct-4 express Oct-4 (lane 4). RT–PCR was performed 48 hours after transfection. Oct-4 is run on a separate gel owing
to the larger product size.
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bestowed upon them a greater developmental potency, we
tested the ability of the Oct-4-transfected keratinocytes to be
driven down a neuroectodermal pathway, the pathway
seemingly favored by undifferentiated ES cells (Hemmati-
Brivanlou and Melton, 1997; Tropepe et al., 2001). In order
to do this, freshly isolated keratinocytes were transfected with
pcDNA3-Oct-4, and then cultured for 7 days in neuroecto-
dermal differentiation medium (detailed in Materials and
Methods). Controls were untransfected keratinocytes grown
for 7 days in keratinocyte defined keratinocyte serum-free
medium (DKSFM) or in neuroectodermal differentiation
medium, and keratinocytes transfected with the control
plasmid pcDNA3-GFP and grown for 7 days in neuroecto-
dermal differentiation medium. On day 1 post-transfection,
all of the cultures exhibited a characteristic keratinocyte
morphology, with the cells growing in cobblestone-like
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Figure 3. Embryonic gene expression in keratinocytes at 24, 72, and 120 hours post-Oct-4 transfection. (a) Time course for expression of Oct-4 target genes.
(b) Time course for Oct-4 expression in keratinocytes. After 24 hours, keratinocytes express Nanog, Utf1, Rex-1, and Sox-2. This expression is continued at
72 hours post-transfection, with a slight decrease in the level of Sox-2. At 120 hours post-transfection, (b) Oct-4 is no longer expressed, Nanog and Sox-2 are
downregulated, and (a) Utf1 and Rex-1 continue to be expressed.
Figure 4. Phenotypic changes of transfected vs untransfected keratinocytes following culture in neuroectodermal growth medium. (a–c) Untransfected P0
keratinocytes cultured for 7 days in DKSFM. (a) Day 1, (b) day 3, and (c) day 7. (d–f) Untransfected P0 keratinocytes cultured for 7 days in neuroectodermal
growth medium. (d) Day 1, (e) day 2, and (f) day 3. (g–i) P0 keratinocytes transfected with pcDNA3-GFP and cultured for 7 days in neuroectodermal
growth medium. (g) Day 1, (h) day 3, and (i) day 7. (j–l) P0 keratinocytes transfected with pcDNA3-Oct-4 and cultured for 7 days in neuroectodermal medium.
(j) Day1, (k) day3, and (l) day 7.
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clusters (Figure 4a, d, g, and j). By day 3, the untransfected
control cells in the keratinocyte-specific medium, DKSFM,
were still growing in typical keratinocyte clusters (Figure 4b).
The only difference from day 1 was a slight increase in cell
size, which is often found when keratinocytes are cultured
(personal observation). The untransfected keratinocytes in the
neuroectodermal growth medium also maintained their
cluster growth pattern (Figure 4e), although more cells
seemed to be growing singularly than seen in DKSFM. On
day 3, the control-GFP-transfected cells still resembled
keratinocytes in morphology, but they were no longer
growing in tight clusters (Figure 4h). By this same time point,
Oct-4-transfected keratinocytes had assembled into tight
clusters of elongated cells, from the edges of which protruded
cells phenotypically resembling neurons (Figure 4k). On day
7, the untransfected keratinocytes in DKSFM remained
relatively unchanged, maintaining their expected cobble-
stone growth pattern (Figure 4c), whereas the untransfected
cells in neuroectodermal medium (Figure 4f) and the control-
GFP-transfected cultures (Figure 4i) consisted largely of
separately growing, enlarged cells, a trait often associated
with imminent keratinocyte death or terminal differentiation.
In contrast, those transfected with Oct-4 maintained a
neuronal phenotype, with a triangular cell body and lengthy
projections (Figure 4l). These results were consistently
repeatable, suggesting that once a keratinocyte has been
reprogrammed to express several key early developmental
genes through transient transfection with Oct-4, it is more
developmentally potent. In other words, it is now capable of
being induced to become an entirely different type of cell – in
this case, a neuron.
Oct-4-transfected keratinocytes express the neuronal markers
nestin, NeuN, and sox-1 following culture in neuroectodermal
medium
In order to fully confirm a change in cell type from
keratinocyte to neuronal cell, we examined the expression
of two early neuroprogenitor genes, nestin and sox-1, as well
as the nestin protein product and neuronal nuclear protein,
NeuN. After 7 days of culture in neuroectodermal medium
(or control DKSFM), both RNA and protein were collected
from untransfected, control-GFP-transfected, and Oct-4-
transfected keratinocytes. RT–PCR analysis revealed that only
keratinocytes transfected with pcDNA3-Oct-4 and grown in
the neuroectodermal growth medium expressed both the
nestin and sox-1 transcripts. Neither the untransfected
keratinocytes cultured in DKSFM nor those transfected with
the control plasmid pcDNA3-GFP and cultured in neuroec-
todermal growth medium expressed these genes (Figure 5a).
Oct-4-transfected keratinocytes also expressed the nestin and
NeuN protein products, whereas the untransfected and
control-GFP-transfected cells did not (Figure 5b; Figure S2).
Cultured fibroblasts were also negative. The Oct-4-trans-
fected cells underwent a concurrent loss of the keratinocyte-
specific marker, keratin 14 (K14) (Figure 5b), suggesting that
the keratinocytes were de-differentiated by transient expres-
sion of Oct-4 before differentiating into neurons.
DISCUSSION
To determine whether it is possible to revert somatic cells
back to a more developmentally potent state, we examined
the effects of the embryonic transcription factor Oct-4 when
introduced into mouse epidermal interfollicular basal kera-
tinocytes. We chose to transiently transfect the cells rather
than to stably transfect them based on the temporal
expression pattern of Oct-4 in the embryo and the negative
effects seen when Oct-4 is continually activated. In mice and
humans, Oct-4 is expressed in all embryonic cells until
embryonic day 3.5 (mice) or 4.5 (humans); at that point, it is
restricted to the inner cell mass of the blastocyst. By day 7 in
mice and day 8 in humans, Oct-4 is rapidly downregulated,
ultimately becoming restricted solely to the primordial germ
cells (Ovitt and Scholer, 1998; Sadler, 2003). In both in vitro
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Figure 5. Expression of neuronal genes and proteins in transfected vs
untransfected keratinocytes grown under neuroectodermal differentiation
conditions. (a) RT–PCR expression of the neuronal genes, Sox-1 and nestin.
Control untransfected keratinocytes (P0) cultured in DKSFM for 7 days and
keratinocytes (P0) transfected with the control plasmid pcDNA3-GFP and
cultured in neuroectodermal medium for 7 days did not express Sox-1 and
nestin. Keratinocytes (P0) transfected with pcDNA3-Oct-4 and cultured for
7 days in neuroectodermal differentiation medium expressed Sox-1 and
nestin. (b) Western blot analysis of nestin, NeuN, and K14. Lane
1¼ untransfected P0 keratinocytes cultured in DKSFM for 7 days.
Lane 2¼ P0 keratinocytes transfected with the control plasmid pcDNA3-GFP
and cultured for 7 days in neuroectodermal medium. Lane 3¼ P0
keratinocytes transfected with pcDNA3-Oct-4 and cultured for 7 days in
neuroectodermal medium. Lane 4¼P0 keratinocytes transfected with
pcDNA3-GFP and cultured in neuroectodermal differentiation medium for
7 days expressed K14 and did not express NeuN. Lane 5¼ P0 keratinocytes
transfected with pcDNA3-Oct-4 and cultured for 7 days in neuroectodermal
medium underwent a downregulation of K14 and an upregulation of NeuN.
Lane 6¼ P1 neonatal mouse fibroblasts did not express K14 or NeuN.
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and in vivo studies, the level and duration of Oct-4
expression necessary for maintaining pluripotency in em-
bryonic cells has been shown to be under tight control (Niwa
et al., 2000). Prolonged expression often leads to dysplasia
and, depending on the duration, cancer (Monk and Holding,
2001; Hochedlinger et al., 2005).
Immunocytochemical analysis following transfection re-
vealed that not only was Oct-4 expressed, but that it localized
correctly to the nucleus. We also measured the Oct-4 protein
expression level for 7 days and found that it seemed to mirror
the temporal expression pattern seen in the embryo.
Expression of the transcription factor peaked at 48 hours
and was virtually extinguished by 120 hours (day 5). This
peak and subsequent downregulation enabled us to study
what genetic changes occurred in response to Oct-4 and, in
addition, what changes persisted following its downregula-
tion. Despite the wide body of literature concerning Oct-4,
no study to date has examined the effects of introducing Oct-
4 alone directly into a differentiated cell. Other groups have
examined the epigenetic reprogramming of somatic nuclei
through fusion with ES cells (Tada et al., 1997, 2001; Ying
et al., 2002; Flasza et al., 2003) or through nuclear transfer
into eggs or oocytes (Byrne et al., 2003; Mitalipov et al.,
2003; Simmonson and Gurdon, 2005). These studies found
that both fusion and nuclear transfer result in the expression
of Oct-4 in the somatic nuclei and a subsequent increase in
developmental potential. However, none addressed whether
Oct-4 was the primary reprogramming factor or if expression
of Oct-4 alone was sufficient to elicit the noted increases in
developmental potency.
In order to assess Oct-4’s reprogramming ability, we
examined expression of several of its target genes: Sox-2,
Utf1, Rex-1, and Nanog. Sox-2 encodes a High Mobility
Group domain-containing transcription factor that is essential
for maintaining stem cell pluripotency. Shown to be
regulated by Oct-4 (Catena et al., 2004), it also serves as a
cofactor for the ES cell transcription factor (Chew et al.,
2005). Our finding that Sox-2 is not expressed in the
keratinocytes until Oct-4 is present reveals that Oct-4 is
capable of activating expression of its cofactor in a cell in
which Sox-2 is completely dormant. This also places Oct-4 at
the top of the pluripotent signaling cascade. It was previously
unknown if loss of Oct-4 expression in somatic cells would
extinguish expression of Sox-2, as well as all of their
downstream targets (Chew et al., 2005). We have shown
that the loss of Oct-4 does coincide with a downregulation of
Sox-2, but that two of their joint targets, Utf1 and Rex-1,
continue to be expressed even in their absence. Utf1 is the
gene for the ES cell coactivator UTF1 and Rex-1 encodes a
zinc-finger protein found in the early embryo and in
pluripotent ES cells (Ben-Shushan et al., 1998); both have
been identified as Oct-4 targets through the presence of an
octamer element in their regulatory regions (Chew et al.,
2005). The persistence of these transcripts after the down-
regulation of Oct-4/Sox-2 is consistent with the results of a
temporal expression study of embryonic cell genes which
showed that the peak of Utf1 and Rex-1 transcript occurs after
that of Oct-4 (Wang et al., 2004). It is also in keeping with the
proposed in vivo function of these factors as transcriptional
coactivators that maintain the pluripotent state for a period
following Oct-4 extinction (Ben-Shushan et al., 1998; Okuda
et al., 1998). Nanog, which has only recently been shown to
contain an Oct-4/Sox-2-binding element in its promoter
(Kuroda et al., 2005; Rodda et al., 2005), was found to be
downregulated in association with the extinction of both
transcription factors. Previously, Nanog was believed to
function separately from Oct-4, serving to maintain pluripo-
tency through a novel leukemia inhibitory factor/signal
transducers and activators of transcription-3-independent
mechanism (Mitsui et al., 2003). Our finding confirms that
Nanog is under the control of Oct-4 and is not independently
activated, at least in transfected keratinocytes.
Our study has demonstrated Oct-4’s ability to single-
handedly activate key pluripotency-controlling genes in a
differentiated cell. It has also shown that Oct-4 can increase
the developmental potency of the somatic cell, that is, make
the cell more pliant to changing their cell type. We found that
only keratinocytes transfected with the full-length Oct-4
transcript were able to respond to neuroectodermal growth
conditions by acquiring a neuronal phenotype and altering
their gene and protein expression profiles. Control cells
showed no expression of nestin, which encodes a class VI
intermediate filament found in neuroectodermal progenitors
(Lendahl et al., 1990; Jiang et al., 2003), sox-1, a homeobox
gene encoding a High Mobility Group transcription factor
expressed exclusively during early neuroectoderm commit-
ment (Ying et al., 2002; Jiang et al., 2003; Fok and Zandstra,
2005), or the neuronal proteins, nestin and NeuN, a protein
found in most neuronal cell types throughout the nervous
system (Mullen et al., 1992; Wolf et al., 1996). Furthermore,
the percentage of keratinocytes expressing Oct-4 protein at
48 hours seemed to coincide with the number of NeuN-
expressing cells. At 48 hours post-transfection with pcDNA3-
Oct-4, 33% of keratinocytes expressed Oct-4. On day 3 of
culture in neuroectodermal growth medium, 30% of the cells
expressed the neuronal marker, NeuN, suggesting that it was
the cells transfected with Oct-4 that were undergoing a
lineage change. By 7 days in culture, the number of cells
exhibiting a neuronal phenotype increased to 85%, suggest-
ing that the Oct-4-transfected keratinocytes capable of
responding to the neuroectodermal growth medium had
divided. This was supported by the observation that
keratinocytes transfected with Oct-4 exhibited a more rapid
growth pattern than either untransfected or GFP-transfected
cells, with Oct-4-transfected cells populating the entire
culture dish by day 2, compared with day 7 for the
untransfected and control-GFP-transfected cells. Expression
of these markers appeared concurrently with a downregula-
tion of the keratinocyte-specific marker, K14. As these
changes were not seen when the keratinocytes were
transfected with the control pcDNA3-GFP, it indicates that
Oct-4 was directly responsible for increasing the keratino-
cytes’ responsiveness to the different growth condition.
The results of this study support the role of the embryonic
transcription factor Oct-4 as the master regulator of the
pluripotent state. Although other groups have demonstrated
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Oct-4’s ability to maintain embryonic cells in their undiffer-
entiated state, this is the first time that transfection of Oct-4
has been shown to de-differentiate a lineage-committed
somatic cell. Our results demonstrate that skin keratinocytes
can undergo an increase in developmental potential follow-
ing reprogramming through transient expression of the
embryonic transcription factor, Oct-4. In other words, Oct-
4-expressing cells can be differentiated along an entirely
different lineage pathway; in this case, changing from a
keratinocyte to a neuronal cell. The concept that a single
transcription factor is capable of genetically reprogramming
an adult cell has great implications for the in vitro generation
of more developmentally potent cells. Given the number of
basal keratinocytes in the skin and the relative ease with
which these cells can be harvested, they could provide us
with a potentially huge reservoir of reprogrammable cells for
use in cell-based disease therapies.
MATERIALS AND METHODS
Cells
Murine interfollicular epidermal basal keratinocytes were isolated
from the body skin (dorsal and ventral skin only; limbs and head
were not included) of 2-day-old Hsd:ICR (CD-1) neonate mice
(Harlan, Indianapolis, IN). All animal tissues were collected
according to guidelines on ethical treatment of animals with full
approval by The University of Iowa Institutional Animal Care and
Use Committee. Briefly, the skin was incubated in dispase II
overnight at 41C. The epidermis was then mechanically separated
from the underlying dermis, placed in 0.25% trypsin for 30 minutes
at 371C, medium added, and the tube gently shaken to dissociate the
basal keratinocytes. The cells were then centrifuged, resuspended in
DKSFM (Invitrogen/Gibco, Grand Island, NY), and plated on
collagen type IV-coated culture dishes. Murine dermal fibroblasts
were isolated from the dermis by incubation in 3.5% collagenase in
high glucose DMEM (Gibco) at 371C for 1 hour with frequent
shaking. The fibroblasts were pelleted by centrifugation and plated
in DMEMþ 10% fetal bovine serum. Murine W4/129S6 ES cells
came from Dr Baoli Yang’s laboratory. The cells were maintained in
KO-DMEM (Gibco), supplemented with 200 mM L-glutamine (Invi-
trogen, Grand Island, NY), 10 mM MEM non-essential amino acids
(Gibco), 0.1 mM b-mercaptoethanol (Sigma, St Louis, MO), 15% fetal
bovine serum (HyClone, South Logan, UT), and 1,000 U/ml
ESGROs (murine LIF) (Chemicon, Temecula, CA).
Cloning of the full-length Oct-4 cDNA
Total RNA was isolated from P22 murine W4/129S6 ES cells using
Trizol LS reagent (Invitrogen), according to the manufacturer’s
instructions. cDNA was generated as described previously, using
4mg of ES cell RNA. The full-length (1,324 bp) Oct-4 cDNA
transcript was then amplified using primers: 50-GGAGT
GAGCCGTCTTTCCACCAG-30 and 50-ATGACTGTGTGTCCAGTCT
TTAT-30. In accordance with the recommendations of the TOPO TA
Cloning Kit (Invitrogen), the extension time of the PCR reaction was
increased to 20 minutes. The product was run on a 2% agarose gel to
confirm product size and then excised and purified using the
QiaQuick Gel Extraction and Purification Kit (Qiagen, Valencia,
CA). Three microliters of the purified PCR product was used in a
TOPO TA cloning reaction (Invitrogen), as per the manufacturer’s
instructions. Briefly, 3 ml of the Oct-4 PCR product was combined
with 1ml of salt solution and 1 ml of TOPO vector, and incubated for
5 minutes at room temperature. Two microliters of this cloning
reaction was added to a vial of one shot E. coli, mixed, and
incubated on ice for 5 minutes. The bacteria were heat-shocked for
30 seconds at 421C. Following transformation, 250 ml of room
temperature store-operated channels medium was added to the
cells, and the mixture was shaken at 371C for 1 hour. Fifty microliters
of the transformation was spread onto Luria–Bertani plates contain-
ing 100mg/ml ampicillin. The plates were incubated overnight at
371C. Colonies were picked and cultured in Luria–Bertani medium
containing ampicillin for 12–14 hours. The clone was harvested
using the FastPlasmid MiniPrep Kit (Eppendorf, Westbury, NY) and
its sequence confirmed using fluorescent-automated DNA sequen-
cing (DNA Facility, University of Iowa). Ligation of the Oct-4 clone
into the mammalian expression plasmid, pcDNA3 (Invitrogen), was
performed in the lab of Dr Richard L. Eckert, using the restriction
enzymes EcoR1 and Xba1.
Transfection of keratinocytes
Keratinocytes were transiently transfected using Lipofectamine and
PLUS reagent (Invitrogen), according to the manufacturer’s protocol.
Briefly, 4 105 freshly isolated keratinocytes were seeded onto each
well of a collagen-IV-coated two-well LabTek Chamber slide (Nunc).
The cells were allowed to plate overnight in complete DKSFM (with
antibiotics). The medium was then replaced with DKSFM without
antibiotics and the cells were returned to the incubator for
30 minutes. During this time, 2.5 mg of plasmid DNA (pcDNA3-
Oct-4 or pcDNA3-GFP, a gift from Dr Nancy Lill, University of Iowa)
was combined with 8ml of PLUS reagent and antibiotic-free DKSFM
in a reaction volume of 100 ml. The mixture was incubated for
15 minutes at room temperature. This solution was then combined
with 90 ml of antibiotic-free DKSFM and 10 ml of Lipofectamine,
mixed, and incubated for an additional 15 minutes at room
temperature. Following the addition of 800 ml of antibiotic-free
DSKFM, the reaction mixture was added to the keratinocytes for
5 hours at 371C and 5% CO2. After 5 hours, the wells were rinsed
several times, the medium was replaced with complete DKSFM, and
the cells were placed back at 371C and 5% CO2. Gene expression
was assayed starting at 24 h post-transfection, using both immuno-
fluorescence and RT–PCR. For collection of RNA for RT–PCR
analysis, 5 106 keratinocytes were plated on 100 mm collagen-
IV-coated dishes and the transfection conditions were increased to
16 mg of plasmid DNA and 64 ml of PLUS reagent in a volume of
800ml of DKSFM, combined with 80 ml of Lipofectamine in 720ml of
DKSFM, plus an additional 1.6 ml.
Semiquantitative RT–PCR
Total RNA was isolated from cells using the RNAqueous Kit
(Ambion, Austin, TX), according to the manufacturer’s instructions.
cDNA was generated through a RT reaction consisting of the
following: 1.5 mg of RNA; 50mM Random Primer (Invitrogen); 5 RT
Buffer (Invitrogen); 0.1 M dithiothreitol (Invitrogen); 10 mM deoxy-
nucleoside triphosphate mix (Qiagen); 40 IU RNasin (Promega,
Madison, WI); 200 IU RTase (Invitrogen); and nuclease-free DEPC-
treated (diethyl pyrocarbonate) water (Amresco, Solon, OH). The
RNA, Random Primer, and water were combined first and heated at
701C for 10 minutes, then chilled on ice. Following addition of the
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other components, the RT reaction was incubated at 251C for
10 minutes, 421C for 1 hour, and then 701C for 15 minutes, using a
GeneMate Genius thermocycler (ISC Bioexpress, Kaysville, UT), and
then chilled on ice. Two microliters of cDNA template was then
added to 23 ml of the following reaction mixture: 10 PCR Buffer
(Qiagen); nuclease-free DEPC water; 2.5 mM deoxynucleoside
triphosphates (Invitrogen); 5 IU Taq polymerase (Qiagen); and
10 mM each primer. The following primers were used: GAPDH
(GenBank M32599), 50-GACTTCAACAGCAACTCCCAC-30 and 50-
TCCACCACCCTGTTGCTGTA-30 (135 bp); Oct-4 (GenBank NM013
633), 50-TGGAGACTTTGCAGCCTGAG-30 and 50-TGAATGCATGG
GAGAGCCCA-30 (800 bp); Nanog (GenBank AY278951), 50-AGGG
TCTGCTACTGAGATGCTCTG-30 and 50-CAACCACTGGTTTTTCTG
CCACCG-30 (360 bp); Utf1 (GenBank NM009482), 50-ACGTGGAG
CATCTACGAGGT-30 and 50-TAGACTGGGGGTCGTTTCTG-30
(154 bp); Rex-1 (GenBank NM009556), 50-GGCCAGTCCAGAATAC
CAGA-30 and 50-GAACTCGCTTCCAGAACCTG-30 (232 bp); Sox-2
(GenBank NM011443), 50-TAGCACTTGTTGCCAGAACG-30 and 50-
AAGCCGCTCTTCTCTTTTCC-30 (340 bp); nestin (GenBank NM016
701), 50-GGAGTGTCGCTTAGAGGTGC-30 and 50-TCCAGAAAGC
CAAGAGAAGC-30 (301 bp); and Sox-1 (GenBank NM011443), 50-
AAGATGCACAACTCGGAGATCAG-30 and 50-TGTAATCCGGGTGT
TCCTTCAT-30 (171 bp). All PCR reactions were run using a standard
profile: denaturation at 941C for 30 seconds, followed by annealing
for 1 minute, and then extension at 721C for 1 minute. For Oct-4
amplification, an annealing temperature of 581C was used and the
PCR was run for 35 cycles. For amplification of Nanog, Utf1, Rex-1,
and Sox-2, an annealing temperature of 571C was used over 35
cycles. Nestin and Sox-2 reactions were performed using an
annealing temperature of 561C for 30 cycles. Product sizes were
confirmed by running 10ml of amplified sample on a 1% agarose gel.
Immunofluorescence
Immunocytochemical analyses were performed on cells plated on
two-well permanox chamber slides. Cells were fixed in 4%
paraformaldehyde for 2 hours at room temperature, rinsed with
1 phosphate-buffered saline, and permeabilized with 0.1% Triton
X-100 for 10 minutes at room temperature. Cells were then rinsed
with 1 phosphate-buffered saline and blocked in 4% normal goat
serum for 2 hours at 41C. Following block, cells were incubated with
a rabbit polyclonal antibody directed against Oct-4 (1:1,000; catalog
no. H-134; Santa Cruz Biotechnology, Santa Cruz, CA) or NeuN
(1:600; catalog no. MAB377; Chemicon, Temecula, CA) for 2 hours
at room temperature. Following primary antibody incubation, cells
were rinsed with phosphate-buffered saline and incubated with a
goat anti-rabbit or rabbit anti-mouse AlexaFluor488 antibody (1:500;
Molecular Probes, Eugene, OR) for 45 minutes at room temperature.
After removal of the secondary antibody with phosphate-buffered
saline washes, cells were mounted with VectaShield Mounting
Medium with 40,60-diamidino-2-phenylindole (Vector Laboratories,
Burlingame. CA) and images captured with a SPOT InSight digital
camera (Diagnostic Instruments, Sterling Heights, MI) on a Nikon
Eclipse E600 epi-fluorescence microscope (Nikon, Melville, NY).
Immunoblotting
For Western blot analysis of nestin, NeuN, K14, and actin, nuclear
and cytoplasmic protein extract was collected from keratinocytes
using the NE-PER Nuclear and Cytoplasmic Extraction Kit (Pierce
Biotechnology, Rockford, IL). Protein concentrations were deter-
mined using the Micro BCA Protein Assay Kit (Pierce Biotechnology)
and 20 mg of each sample were loaded onto a 12% polyacrylamide
gel and run at 200 V for 1 hour. The protein was then transferred to a
nitrocellulose membrane at 100 mAmp for 12 hours. Following
transfer, the membrane was rocked in a blocking solution (4% non-
fat dry milk and 0.3% Tween-20 in 1 phosphate-buffered saline)
for 2 hours at room temperature. The membrane was then incubated
with a rabbit polyclonal antibody directed against nestin (1:200;
catalog no. sc-21249; Santa Cruz Biotechnology), a rabbit poly-
clonal directed against cytokeratin 14 (1:500; catalog no. PRB-155P;
Covance, Philadelphia, PA), a mouse mAb directed against NeuN
(1:500; catalog no. MAB377; Chemicon), or a mouse mAb directed
against actin (1:1,000; catalog no. AC-40; Sigma) for 2 hours at room
temperature. Primary antibody was removed by washing with Tris-
buffered saline with Tween (1 Tris-buffered saline with 0.5%
Tween-20) and the membrane was then incubated with an anti-
rabbit (IRDye TM800 anti-Rabbit IgG 1:2,500, 611-132-122, Rock-
land Inc., Gilbertsville, PA) or anti-mouse infrared secondary
antibody IRDyeTM 800 anti-Mouse IgG 1:5,000, 610-132-121,
Rockland Inc.) for 45 minutes at room temperature. Following
removal of secondary antibody through sequential washing with
Tris-buffered saline with Tween and Tris-buffered saline, protein
was detected with the use of an Odyssey Infrared Imaging System
(LI-COR Biotechnology, Lincoln, NE).
Neuroectodermal differentiation of keratinocytes
Medium conditions for neuroectodermal differentiation of
keratinocytes were derived from Jiang et al. (2003). Briefly,
basal medium was established through the combination of the
following: 60% DMEM low glucose (Gibco) and 40% MCDB-201
(Sigma), supplemented with 1 insulin-transferrin-selenium (Sig-
ma), 1 linoleic acid-albumin (Sigma), 109 M dexamethasone
(Sigma), and 104 ascorbic acid (Sigma). The basal medium was
then supplemented with 100 ng/ml basic fibroblast growth factor
(Sigma), 100 ng/ml Sonic Hedgehog (Cell Sciences, Inc., Canton,
MA), 10 ng/ml fibroblast growth factor-8 (Cell Sciences, Inc.), and
10 ng/ml brain-derived neurotrophic factor (Cell Sciences, Inc.).
Cells were then cultured for 7 days, with the medium renewed on
days 3 and 6.
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SUPPLEMENTARY MATERIAL
Figure S1. Expression of the Oct-4 transcription factor following transient
transfection of keratinocytes with the full-length Oct-4 cDNA.
Figure S2. NeuN protein expression in Oct-4-transfected keratinocytes
following 7 days culture in neuroectodermal differention medium.
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